Wall Street Journal - Insider Narrative

India regulator finds BofA shared confidential information ahead of block trade, WSJ reports

This post was originally published on this site. India’s markets regulator has found that Bank of America improperly shared material non-public information about a $180 million block trade of stock and misled the authorities about it, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

Wall Street Journal

Exclusive | Regulator Finds Bank of America Shared Confidential Information Ahead of Block Trade

This post was originally published on this site. India’s securities officials determined that the bank misled investigators about a 2024 $180 million stock transaction.

Wall Street Journal

JPMorgan reaches deal to take over Apple credit card, WSJ reports

This post was originally published on this site. JPMorgan Chase has reached a deal to take over Apple credit-card program from Goldman Sachs , the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

Wall Street Journal

Polymarket, Dow Jones Partner to Display Prediction-Markets Data in Dow Jones Content

This post was originally published on this site. Data from Polymarket on betting odds for economic, political, and cultural topics would be displayed in dedicated modules across Dow Jones’s online content platforms, which include the Journal, MarketWatch, Barron’s and Investor’s Business Daily.

Wall Street Journal

Exclusive | JPMorgan Chase Reaches a Deal to Take Over the Apple Credit Card

This post was originally published on this site. After more than a year of negotiations, a deal to take over Goldman Sachs’s role in Apple program is expected to be announced soon

Wall Street Journal

Trump Orders Crackdown on Defense Industry Stock Buybacks

This post was originally published on this site. In an executive order, the president will seek to cap defense bosses’ pay and demand that contractors invest in production capacity.

Wall Street Journal

AbbVie Close to Deal for Cancer Drugmaker RevMed, WSJ Says

This post was originally published on this site. AbbVie Inc. is in “advanced” talks to purchase Revolution Medicines Inc., a cancer focused biotech, in a deal that could be worth more than $20 billion, according to a report in the Wall Street Journal, citing people familiar with the matter.